The phosphorylation of GSK-3β (ser9) can inhibit its enzymatic activity and suppress the degradation of β-catenin, which causes epithelial-mesenchymal transformation, renal fibrosis, and tight junction destruction characterized by the down-regulation of E-cadherin (Sun et al., 2016). The gene discussed is GSK3B; the disease is renal fibrosis.